Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR/β‑catenin/N‑cadherin axis

Chul Geun Kim(Taoka Hospital), Hirokazu Inoue(Shiga University of Medical Science)
International Journal of Oncology
May 13, 2021
Cited by 18


Related Papers